<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T4" position="float">
 <label>TABLE 4</label>
 <caption>
  <p>List of studies on the anti-inflammatory effects of genus 
   <italic>Gynura.</italic>
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="1" colspan="1">Plant species</th>
    <th align="center" rowspan="1" colspan="1">Part, 
     <italic>Gynura</italic> form
    </th>
    <th align="center" rowspan="1" colspan="1">Cell line/Animal study model</th>
    <th align="center" rowspan="1" colspan="1">Concentration/dose, control groups</th>
    <th align="center" rowspan="1" colspan="1">Parameter measured and technique used</th>
    <th align="center" rowspan="1" colspan="1">Findings</th>
    <th align="center" rowspan="1" colspan="1">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="56" colspan="1">Gynura procumbens (Lour.) Merr.</td>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">Human HaCaT keratinocytes</td>
    <td align="left" rowspan="1" colspan="1">100, 500 μg/ml (24 h)</td>
    <td rowspan="1" colspan="1">IL-6 and IL-8 production level using ELISA</td>
    <td rowspan="2" colspan="1">By 100 and 500 μg/ml GP extract, IL-6 and IL-8 were inhibited.</td>
    <td rowspan="6" colspan="1">
     <xref rid="B30" ref-type="bibr">Kim et al. (2011)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Extract (Ethanol)</td>
    <td rowspan="1" colspan="1">Human dermal fibroblasts (HDFs)</td>
    <td align="left" rowspan="1" colspan="1">1, 10, 20 μg/ml (48 h)</td>
    <td rowspan="1" colspan="1">MMP-1 expression using western blotting</td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1"> 
     <italic>In vitro</italic> study stimulated by UV irradiation
    </td>
    <td rowspan="1" colspan="1">Control groups:</td>
    <td rowspan="4" colspan="1">MMP-9 expression using Zymography</td>
    <td rowspan="4" colspan="1">GP extract dose-dependently inhibited MMP-1 and MMP-9 expression in UV-B irradiated HDFs.</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (UV 40 mJ/cm
     <sup>2</sup>)
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Positive control (10 μM Retinoic acid)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Leaf, stem</td>
    <td rowspan="1" colspan="1">RAW 264.7 macrophages</td>
    <td align="left" rowspan="1" colspan="1">GPEO: 0.003, 0.01, 0.03 μg/ml</td>
    <td rowspan="6" colspan="1">Inhibition on inflammatory cell infiltrates using migration assay</td>
    <td rowspan="6" colspan="1">GPEO ↓↓↓ LPS-induced cell migration. Limonene, but not α-pinene, 3-carene, or their components mixture, ↓↓↓ cell migration.</td>
    <td rowspan="6" colspan="1">
     <xref rid="B24" ref-type="bibr">Huang et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Essential oil and its active ingredients</td>
    <td rowspan="5" colspan="1"> 
     <italic>In vitro</italic> study stimulated by LPS
    </td>
    <td rowspan="1" colspan="1">Active ingredients: concentration not stated</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Treatment time not stated</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (LPS)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Extract (Ethanol)</td>
    <td rowspan="5" colspan="1"> 
     <italic>In vitro</italic> study stimulated by LPS
    </td>
    <td align="left" rowspan="1" colspan="1">0.4, 0.6, 0.8 mg/ml</td>
    <td rowspan="5" colspan="1">TNF-α and IL-6 production level using ELISA</td>
    <td rowspan="5" colspan="1">GP extract dose-dependently ↓ IL-6. GP extract at 0.8 mg/ml ↓ TNF-α. Ethyl acetate fraction showed the best inhibitory effect on IL-6 and TNF-α.</td>
    <td rowspan="5" colspan="1">
     <xref rid="B39" ref-type="bibr">Liu M. et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1">Fractions (Petroleum ether, ethyl acetate, n-butanol, water)</td>
    <td rowspan="1" colspan="1"> 24 h incubation with LPS</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (1 μg/ml LPS)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Whole plant</td>
    <td rowspan="1" colspan="1">RAW 264.7 macrophages</td>
    <td align="left" rowspan="1" colspan="1">3.9, 15.63, 62.5 and 250 μg/ml</td>
    <td rowspan="1" colspan="1">Nitric oxide production level using Griess assay</td>
    <td rowspan="1" colspan="1">Pre-treatment of 250 μg/ml GP:</td>
    <td rowspan="6" colspan="1">
     <xref rid="B53" ref-type="bibr">Ning et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Extract (Ethanol)</td>
    <td rowspan="5" colspan="1"> 
     <italic>In vitro</italic> study stimulated by LPS
    </td>
    <td rowspan="1" colspan="1"> 1 h pre-treatment</td>
    <td rowspan="5" colspan="1">iNOS protein expression using western blotting</td>
    <td rowspan="1" colspan="1">↓ NO production (dose dependent)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
    <td rowspan="4" colspan="1">↓ iNOS protein expression.</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Vehicle control (0.1% DMSO)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (1 μg/ml LPS)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">Mice normal liver cell line NCTC-1469</td>
    <td rowspan="1" colspan="1">80 and 160 μg/ml (24 h)</td>
    <td rowspan="4" colspan="1">Nrf2 and 
     <italic>p</italic>-JNK protein expressions using western blotting
    </td>
    <td rowspan="1" colspan="1">80 μg/ml GP treatment ↑ Nrf2 protein level, ↓ 
     <italic>p</italic>-JNK
    </td>
    <td rowspan="4" colspan="1">
     <xref rid="B41" ref-type="bibr">Liu Y. et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1">Extract (Aqueous)</td>
    <td rowspan="3" colspan="1"> 
     <italic>In vitro</italic> study transfected with Ad-shCFLAR
    </td>
    <td rowspan="1" colspan="1">Control groups:</td>
    <td align="left" rowspan="3" colspan="1">160 μg/ml GP treatment ↑ Nrf2 protein levels, ↓↓ 
     <italic>p</italic>-JNK
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control (Ad-shCtrl)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (pre-treated with Ad-shCFLAR for 24 h)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">RAW 264.7 macrophages</td>
    <td align="left" rowspan="1" colspan="1">15.63, 31.25, 62.5, 125, 250, 500 μg/ml</td>
    <td rowspan="4" colspan="1">Nitric oxide production level using Griess assay</td>
    <td rowspan="4" colspan="1">GP extract showed anti-inflammatory activity by inhibiting NO production</td>
    <td rowspan="4" colspan="1">
     <xref rid="B11" ref-type="bibr">Chandradevan et al. (2020)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1">Extract (Ethanol)</td>
    <td rowspan="3" colspan="1"> 
     <italic>In vitro</italic> study stimulated by LPS
    </td>
    <td rowspan="1" colspan="1">Control groups:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (IFN-γ + LPS)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Aerial part</td>
    <td rowspan="1" colspan="1">Balb/c white mice (5 mice/group)</td>
    <td rowspan="1" colspan="1">0.75 mg/20 μl</td>
    <td rowspan="6" colspan="1">Ear thickness (anti-inflammatory activity)</td>
    <td rowspan="6" colspan="1">Original organic crude extract ↓↓↓ croton oil-induced ear inflammation.</td>
    <td rowspan="6" colspan="1">
     <xref rid="B26" ref-type="bibr">Iskander et al. (2002)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Extract (Ethanol)</td>
    <td rowspan="5" colspan="1"> 
     <italic>In vivo</italic> study using croton oil-induced ear inflammation mice model
    </td>
    <td rowspan="1" colspan="1"> Topical application</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> 30 min pre-treatment, ear thickness was measured at 24 h</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (20 μl acetone at left ear + 0.1 mg/20 μl/ear croton oil)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Standard anti-inflammatory agent (hydrocortisone)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">Male BALB/c mice (5 mice/group)</td>
    <td rowspan="1" colspan="1">50 mg/kg body weight</td>
    <td rowspan="1" colspan="1">GSK3β phosphorylation using western blotting</td>
    <td rowspan="1" colspan="1">GP ↑ phosphorylation of liver GSK3β (Ser9) compared with non-treated control</td>
    <td rowspan="6" colspan="1">
     <xref rid="B92" ref-type="bibr">Wong et al. (2015)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Extract (Ethanol)</td>
    <td rowspan="5" colspan="1"> 
     <italic>In vivo</italic> study using parasite-infected mice model
    </td>
    <td rowspan="1" colspan="1">Intraperitoneally treated</td>
    <td align="left" rowspan="5" colspan="1">TNF-α, IFN-γ and IL-10 production level using ELISA</td>
    <td rowspan="1" colspan="1">↓ TNF-α and IFN-γ levels in liver and serum by administration of GP</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> 1 day pre-infection</td>
    <td rowspan="4" colspan="1">↑ IL-10 level in serum.</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (B. pseudomallei infection)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Leaf, stem</td>
    <td rowspan="1" colspan="1">50 male Kunming mice (5 mice/group)</td>
    <td rowspan="1" colspan="1">GPEO: 0.433, 0.865, 1.73 mg/ml</td>
    <td rowspan="1" colspan="1">Ear thickness by xylene-induced ear edema</td>
    <td rowspan="2" colspan="1">GPEO ↓↓ xylene-induced ear and hind paw edema at all doses throughout experiment. Treatment with active ingredients mixture ↓ ear and hind paw edema.</td>
    <td rowspan="7" colspan="1">
     <xref rid="B24" ref-type="bibr">Huang et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="6" colspan="1">Essential oil and its active ingredients</td>
    <td rowspan="6" colspan="1"> 
     <italic>In vivo</italic> study using xylene and formalin-induced inflammation mice model
    </td>
    <td align="left" rowspan="1" colspan="1">Active ingredients: α-pinene (0.174 mg/ml), 3-carene (0.153 mg/ml), limonene (0.036 mg/ml) and mixture of all 3 ingredients</td>
    <td rowspan="1" colspan="1">Hind paw edema using micrometre and histological examination</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Topical administration</td>
    <td rowspan="5" colspan="1">COX-2 expression using immunohistochemical staining and multispectral imaging analysis</td>
    <td rowspan="1" colspan="1">↓ COX-2 expression by 0.865 mg/ml GPEO and all 3 individual and mixture of active ingredients.</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
    <td rowspan="4" colspan="1">↓↓ COX-2 expression by 1.73 mg/ml GPEO.</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Untreated control</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (topical application of sesame oil + 20 μl xylene, intradermal injection of 20 μl 4% formalin)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Positive control (diclofenac diethylamine emulgel (DDE))</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">32 Male C57BL/6J mice (8 mice/group)</td>
    <td rowspan="1" colspan="1">500 and 1,000 mg/kg body weight</td>
    <td rowspan="1" colspan="1">Nrf2 and 
     <italic>p</italic>-JNK protein expressions using western blotting
    </td>
    <td rowspan="2" colspan="1">500 mg/kg GP treatment ↑ Nrf2 protein level, no obvious effect on 
     <italic>p</italic>-JNK, ↑ PPARγ mRNA expression.
    </td>
    <td rowspan="6" colspan="1">
     <xref rid="B41" ref-type="bibr">Liu Y. et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Extract (Aqueous)</td>
    <td rowspan="5" colspan="1"> 
     <italic>In vivo</italic> study using non-alcoholic steatohepatitis (NASH) mic
    </td>
    <td rowspan="1" colspan="1"> Oral route</td>
    <td rowspan="5" colspan="1">mRNA expression of PPARγ using RT-qPCR</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Daily for 6 weeks</td>
    <td rowspan="4" colspan="1">1000 mg/kg GP treatment ↑ protein levels of hepatic Nrf2, ↓ protein level of hepatic 
     <italic>p</italic>-JNK, ↑↑ PPARγ mRNA expression.
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control (methionine- and choline-sufficient (MCS) diet)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Model control (methionine- and choline-deficient (MCD) diet)</td>
   </tr>
   <tr>
    <td rowspan="30" colspan="1">Gynura bicolor (Roxb. ex Willd.) DC</td>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">RAW 264.7 macrophages</td>
    <td align="left" rowspan="1" colspan="1">15, 30, 60, or 120 μg/ml</td>
    <td rowspan="1" colspan="1">Nitric oxide production level using Griess assay</td>
    <td rowspan="1" colspan="1">↓ NO production (30% decrease with 120 μg/ml GB)</td>
    <td rowspan="7" colspan="1">
     <xref rid="B94" ref-type="bibr">Wu et al. (2013)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="6" colspan="1">Extract (Ether)</td>
    <td rowspan="6" colspan="1"> 
     <italic>In vitro</italic> study stimulated by LPS
    </td>
    <td rowspan="1" colspan="1"> 3 h pre-treatment</td>
    <td rowspan="1" colspan="1">PGE2 production using competitive enzyme immunoassay (EIA) kit</td>
    <td rowspan="1" colspan="1">↓ PGE2 production (dose dependent)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
    <td rowspan="1" colspan="1">iNOS, COX-2, phosphorylated-IκBα and p65 protein expression using immunoblot analysis</td>
    <td rowspan="1" colspan="1">↓ iNOS and COX-2 protein expressions (concentration dependent)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Vehicle control group (0.1% (v/v) methanol)</td>
    <td rowspan="4" colspan="1">NF-κB DNA-binding activity by Nuclear protein preparation and electrophoretic mobility shift assay (EMSA</td>
    <td rowspan="1" colspan="1">↓ 
     <italic>p</italic>-IκBα protein (47% decrease with 120 μg/ml GB)
    </td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1"> Model control (1 μg/ml LPS)</td>
    <td align="left" rowspan="1" colspan="1">↓ nucleic p65 protein levels (3–41% decrease with 30, 60, 120 μg/ml GB)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">↓ translocation of NF-κB from the cytosol to nuclei</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">↓ DNA-binding activity of NF-κB nuclear protein by 30, 60, 120 μg/ml GB</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">Human umbilical vein endothelial cells (HUVEC)</td>
    <td align="left" rowspan="1" colspan="1">Aqueous or ethanol extract at 1, 2 or 4% (v/v)</td>
    <td rowspan="1" colspan="1">IL-6 and TNF-α production using cytoscreen immunoassay</td>
    <td rowspan="1" colspan="1">Pre-treatments with aqueous or ethanol extract of GB at 2 and 4%</td>
    <td rowspan="5" colspan="1">
     <xref rid="B12" ref-type="bibr">Chao et al. (2015)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1">Extract (Aqueous, Ethanol)</td>
    <td rowspan="4" colspan="1"> 
     <italic>In vitro</italic> study treated by high glucose
    </td>
    <td rowspan="1" colspan="1"> 12 h pre-treatment</td>
    <td rowspan="1" colspan="1">Prostaglandin E (PGE2) production</td>
    <td align="left" rowspan="1" colspan="1">↓ IL-6, TNF-α formation</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
    <td rowspan="3" colspan="1">Cyclooxygenase (COX)-2 activity</td>
    <td rowspan="1" colspan="1">↓ PGE2 formation</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Control (5.5 mM glucose)</td>
    <td rowspan="2" colspan="1">↓ COX-2 activity.</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (33 mM glucose)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">PC12 cell line (rat adrenal gland pheochromocytoma)</td>
    <td align="left" rowspan="1" colspan="1">Aqueous extract at 0.25, 0.5 or 1%</td>
    <td rowspan="1" colspan="1">LDH activity</td>
    <td rowspan="1" colspan="1">↓ LDH activity in concentration dependent manner</td>
    <td rowspan="5" colspan="1">
     <xref rid="B97" ref-type="bibr">Yang et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1">Extract (Aqueous)</td>
    <td rowspan="4" colspan="1"> 
     <italic>In vitro</italic> study of H2O2 induced injury
    </td>
    <td rowspan="1" colspan="1"> 48 h pre-treatment</td>
    <td rowspan="1" colspan="1">Mitochondrial membrane potential (Δψm) using fluorescent dye Rh123</td>
    <td rowspan="1" colspan="1">↑ Δψm in concentration dependent manner</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
    <td align="left" rowspan="1" colspan="1">IL-6, IL-1β and TNF-α production level by cytoscreen assay</td>
    <td align="left" rowspan="1" colspan="1">↓ IL-6, IL-1β and TNF-α production level</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
    <td rowspan="2" colspan="1">NF-κB and p38 mRNA expression using RT-PCR</td>
    <td align="left" rowspan="1" colspan="1">Test concentrations (0.25, 0.5 and 1%) ↓ NF-κB mRNA expression</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (H2O2 stimulation)</td>
    <td rowspan="1" colspan="1">0.5 and 1% extract ↓ p38 mRNA expression.</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">Male C57BL/6 mice (8 mice/group)</td>
    <td rowspan="1" colspan="1">0.25 or 0.5% G. bicolor aqueous extract diet</td>
    <td align="left" rowspan="7" colspan="1">Hepatic levels of IL-1β, IL-6 and TNF-α using cytoscreen immunoassay kits</td>
    <td align="left" rowspan="7" colspan="1">GB dose-dependently ↓ hepatic levels of inflammatory cytokines of IL-1β, IL-6 and TNF-α.</td>
    <td rowspan="7" colspan="1">
     <xref rid="B98" ref-type="bibr">Yin et al. (2017)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="6" colspan="1">Extract (Aqueous)</td>
    <td rowspan="6" colspan="1"> 
     <italic>In vivo</italic> study using chronic ethanol consumption-induced hepatic injury mice model
    </td>
    <td rowspan="1" colspan="1"> Oral route</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> 6 weeks</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Liquid diet group (without ethanol)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Ethanol diet group</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">50 male Balb/cA mice (10 mice/group)</td>
    <td align="left" rowspan="1" colspan="1">0.25, 0.5, 1% GB diet</td>
    <td align="left" rowspan="1" colspan="1">Cardiac or renal level of IL-1β, IL-6 or TNF-α using cytoscreen immunoassay kits</td>
    <td rowspan="1" colspan="1">GB at 3 doses:</td>
    <td rowspan="6" colspan="1">
     <xref rid="B54" ref-type="bibr">Pai et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Extract (Aqueous)</td>
    <td rowspan="5" colspan="1"> 
     <italic>In vivo</italic> Streptozotocin-induced type 1 diabetic mice model
    </td>
    <td rowspan="1" colspan="1"> Oral route</td>
    <td rowspan="5" colspan="1">p38 and NF-κB mRNA expression using RT-PCR</td>
    <td align="left" rowspan="1" colspan="1">↓ level of IL-1β, IL-6, and TNF-α in heart and kidney</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> 8 weeks</td>
    <td rowspan="4" colspan="1">↓ p38 and NF-κB mRNA expression in heart or kidney</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control (basal diet)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Diabetic model control (40 mg/kg BW streptozotocin (in citrate buffer, 0.1 M) via i.p. injection for 5 days)</td>
   </tr>
   <tr>
    <td rowspan="26" colspan="1">
     <italic>Gynura pseudochina</italic> (L.) DC.
    </td>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">HeLa cells</td>
    <td rowspan="1" colspan="1">0.2–200 μg/ml</td>
    <td rowspan="1" colspan="1">IL-6/luciferase assay (NF-κB assay)</td>
    <td rowspan="7" colspan="1">
     <italic>Gynura pseudochina</italic> var. hispida (MeOH) showed the strongest NF-κB inhibitory effects, as well as inhibition on release of IL-1, IL-6, TNF-α and PGE2.
    </td>
    <td rowspan="7" colspan="1">
     <xref rid="B70" ref-type="bibr">Siriwatanametanon et al. (2010)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="6" colspan="1">Extract (Methanol, Ethyl acetate, Petroleum ether)</td>
    <td rowspan="1" colspan="1">
     <italic>In vitro</italic> study stimulated by PMA
    </td>
    <td align="left" rowspan="1" colspan="1">1, 10 and 50 μg/ml</td>
    <td align="left" rowspan="6" colspan="1">IL-6, IL-1, TNF-α and PGE2 production level using ELISA and EIA</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Monocytes from healthy human donors</td>
    <td rowspan="1" colspan="1"> 24 h</td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1"> 
     <italic>In vitro</italic> study stimulated by LPS
    </td>
    <td rowspan="1" colspan="1">Control groups:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Positive control (ethanol)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Negative control (Unstimulated cells)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Reference group (Parthenolide, hydrocortisone)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">HeLa cells</td>
    <td rowspan="1" colspan="1">Non-toxic concentrations (using the MTT assay)</td>
    <td rowspan="6" colspan="1">IL-6/luciferase assay (NF-κB assay)</td>
    <td rowspan="1" colspan="1">Quercetin 3-rutinoside showed the highest NF-κB inhibitory effect.</td>
    <td rowspan="6" colspan="1">
     <xref rid="B71" ref-type="bibr">Siriwatanametanon and Heinrich (2011)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Isolated compound from methanol extract</td>
    <td rowspan="5" colspan="1"> 
     <italic>In vitro</italic> study stimulated by PMA
    </td>
    <td rowspan="1" colspan="1">Control groups:</td>
    <td rowspan="1" colspan="1">NF-κB inhibitory activities IC50:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Positive control (ethanol)</td>
    <td rowspan="1" colspan="1">Quercetin 3-rutinoside: 24.1 ± 0.1 μg/ml</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Negative control (Unstimulated cells)</td>
    <td align="left" rowspan="1" colspan="1">3,5-di-caffeoylquinic acid: 42.8 ± 0.2 μg/ml</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Reference group (Parthenolide)</td>
    <td align="left" rowspan="1" colspan="1">4,5-di-caffeoylquinic acid: 49.1 ± 0.1 μg/ml</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">5-mono-caffeoylquinic acid: 83.0 ± 0.1 μg/ml</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">Human HaCaT keratinocytes</td>
    <td rowspan="1" colspan="1">Extract: 375 and 750 μg/ml</td>
    <td rowspan="1" colspan="1">IL-8 production level using ELISA</td>
    <td rowspan="1" colspan="1">Extract at both tested concentrations and some concentration of each marker compounds:</td>
    <td rowspan="10" colspan="1">
     <xref rid="B73" ref-type="bibr">Sukadeetad et al. (2018)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="9" colspan="1">Extract (Ethanol), marker compounds</td>
    <td rowspan="9" colspan="1">
     <italic>In vitro</italic> study stimulated by TNF-α
    </td>
    <td rowspan="1" colspan="1">Chlorogenic acid: 140 and 280 μg/ml</td>
    <td rowspan="9" colspan="1">RelA and RelB localization by immunofluorescence assay</td>
    <td rowspan="1" colspan="1">↓ IL-8 production level</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Caffeic acid: 30 and 60 μg/ml</td>
    <td rowspan="8" colspan="1">↓ translocation of RelB S573 into nucleus</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Rutin: 750 and 1,500 μg/ml</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>p</italic>-coumaric acid: 1,400 and 2,800 μg/ml
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> 24 h</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (50 ng/ml TNF-α with/without 0.7% DMSO)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Positive control (50 μg/ml curcumin)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">25 patients with mild to moderate plaque psoriasis</td>
    <td rowspan="1" colspan="1">Mixture of extract and vehicle (1:10)</td>
    <td rowspan="3" colspan="1">Phosphorylation of NF-κB p65 using immunohistochemistry (skin sections from two patients)</td>
    <td rowspan="3" colspan="1">Immunohistochemical staining revealed diminution of phosphorylated NF-κB p65 in the lesions treated with the GP ointment.</td>
    <td rowspan="3" colspan="1">
     <xref rid="B58" ref-type="bibr">Rerknimitr et al. (2016)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">Ointment from ethanol extract</td>
    <td rowspan="2" colspan="1"> Randomized controlled study</td>
    <td rowspan="1" colspan="1">Twice daily for 4 weeks</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control: 0.1% triamcinolone cream</td>
   </tr>
   <tr>
    <td rowspan="13" colspan="1">
     <italic>Gynura divaricata</italic> (L.) DC.
    </td>
    <td rowspan="1" colspan="1">Leaf, stem</td>
    <td rowspan="1" colspan="1">60 male imprinting control region mice (15 mice/group)</td>
    <td rowspan="1" colspan="1">Diets with 1.2 and 4.8% GD</td>
    <td rowspan="1" colspan="1">Pancreatic Akt, PI3K, and PDK-1 mRNA expressions using qPCR</td>
    <td rowspan="1" colspan="1">1.2% GD:</td>
    <td rowspan="6" colspan="1">
     <xref rid="B96" ref-type="bibr">Xu et al. (2015)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Lyophilized into powder</td>
    <td rowspan="5" colspan="1">
     <italic>In vivo</italic> study using high-fat diet and streptozotocin (STZ) induced type 2 diabetic mice
    </td>
    <td rowspan="1" colspan="1"> Oral route</td>
    <td rowspan="5" colspan="1">Pancreatic 
     <italic>p</italic>-Akt, PI3K, and PDK-1 protein expressions using western blotting
    </td>
    <td rowspan="2" colspan="1">↑ Akt mRNA, ↑ 
     <italic>p</italic>-Akt protein expression, ↑ PI3K mRNA and protein expression, ↑ PDK-1 mRNA and protein expression
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Daily for 4 weeks</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
    <td rowspan="1" colspan="1">4.8% GD:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control (Normal diet)</td>
    <td rowspan="2" colspan="1">↑↑ Akt mRNA, ↑↑ 
     <italic>p</italic>-Akt protein expression, ↑↑ PI3K mRNA and protein expression, ↑↑ PDK-1 mRNA, ↑ PDK-1 protein expression.
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Diabetic model control (high-fat diet (18% lard, 20% sugar, 3% egg yolk, 59% basal diet) and 100 mg/kg STZ)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Aerial part</td>
    <td rowspan="1" colspan="1">Male ICR mice (15 mice/group)</td>
    <td rowspan="1" colspan="1">Diets with 1, 5 and 10% GD</td>
    <td rowspan="1" colspan="1">Western blotting to determine hepatic protein expression of</td>
    <td align="left" rowspan="3" colspan="1">1% GD: ↑ 
     <italic>p</italic>-GSK3β, ↑ PPARγ
    </td>
    <td rowspan="7" colspan="1">
     <xref rid="B18" ref-type="bibr">Dong et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="6" colspan="1">Lyophilized into powder</td>
    <td rowspan="6" colspan="1"> 
     <italic>In vivo</italic> study using high-fat diet and streptozotocin (STZ) induced type 2 diabetic mice
    </td>
    <td rowspan="1" colspan="1"> Oral route</td>
    <td rowspan="1" colspan="1">phosphatidylinositol 3-kinase (PI3K)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Daily for 4 weeks</td>
    <td rowspan="1" colspan="1">phosphorylated protein kinase B (
     <italic>p</italic>-Akt)
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
    <td rowspan="1" colspan="1">phosphorylated glycogen synthase kinase 3β (
     <italic>p</italic>-GSK3β)
    </td>
    <td rowspan="2" colspan="1">5% GD: ↑ PI3K, ↑ 
     <italic>p</italic>-Akt, ↑ 
     <italic>p</italic>-GSK3β, ↑ PPARγ, ↓ TNF-α
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control (Normal chow)</td>
    <td rowspan="1" colspan="1">PPARγ</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">Model control (high-fat diet (18% lard, 20% sugar, 3% egg yolk and 59% basal diet) and 100 mg/kg STZ)</td>
    <td rowspan="1" colspan="1">Tumor necrosis factor-α (TNF-α)</td>
    <td rowspan="2" colspan="1">10% GD: ↑ PI3K, ↑↑ 
     <italic>p</italic>-Akt, ↑ 
     <italic>p</italic>-GSK3β, ↑↑ PPARγ, ↓ TNF-α, ↓ NF-κB
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Nuclear factor kappa B (NF-κB)</td>
   </tr>
   <tr>
    <td rowspan="11" colspan="1">
     <italic>Gynura</italic> segetum (Lour.) Merr
    </td>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">RAW 264.7 macrophages</td>
    <td rowspan="1" colspan="1">Extract: 6.25–100 μg/ml</td>
    <td rowspan="1" colspan="1">Nitric oxide production level using Griess assay</td>
    <td align="left" rowspan="1" colspan="1">GS extract showed inhibition on NO production with IC50 = 0.16 ± 0.03 μg/ml 8,8′-(ethene-1,2-diyl)-dinaphtalene-1,4,5-triol depicted the strongest NO inhibitory activity with IC50 value of 0.15 μM.</td>
    <td rowspan="1" colspan="1">
     <xref rid="B100" ref-type="bibr">Yuandani et al. (2017)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Extract (Methanol), isolated compound from extract</td>
    <td rowspan="1" colspan="1">Peripheral blood mononuclear cells (PBMCs)</td>
    <td rowspan="1" colspan="1">Compounds: 3.125–50 μg/ml</td>
    <td rowspan="4" colspan="1">IL-1β and TNF-α production level using ELISA</td>
    <td align="left" rowspan="4" colspan="1">GS extract showed IC50 TNF-α = 16.20 ± 3.94 μg/ml; IC50 IL-1β = 2.72 ± 1.84 μg/ml 4,5,4′-trihydroxychalcone demonstrated the highest inhibition on IL-1β release (IC50 = 6.69 μM). Rutin was the most potent sample against TNF-α release with IC50 = 16.96 μM.</td>
    <td rowspan="10" colspan="1">
     <xref rid="B66" ref-type="bibr">Seow et al. (2014)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1"> 
     <italic>In vitro</italic> study induced by LPS (1 μg/ml)
    </td>
    <td rowspan="1" colspan="1"> 3 h (Griess assay) or 12 h pre-treatment (ELISA)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Positive control (0.025 μM Dexamethasone)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Male Sprague-Dawley rats</td>
    <td align="left" rowspan="1" colspan="1">125, 250 and 500 mg/kg body weight</td>
    <td rowspan="1" colspan="1">Cotton pellet granuloma assay</td>
    <td align="left" rowspan="6" colspan="1">GS dose-dependently ↓↓↓ formation of granuloma tissues (17.1, 39.7, and 47.2% inhibition by 125, 250 and 500 mg/kg GS), ↓↓↓ TNF-α and IL-1 levels in circulating pro-inflammatory cytokine levels.</td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Extract (Methanol)</td>
    <td rowspan="5" colspan="1"> 
     <italic>In vivo</italic> study using cotton pellet-induced granuloma rat model
    </td>
    <td rowspan="1" colspan="1"> Oral route</td>
    <td rowspan="5" colspan="1">TNF-α and IL-1 production level using ELISA</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Once daily for 7 days</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Negative control (1% Tween 80)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Reference group (5 mg/kg indomethacin)</td>
   </tr>
   <tr>
    <td rowspan="12" colspan="1">
     <italic>Gynura</italic> nepalensis DC.
    </td>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">H9c2 cardiomyoblasts</td>
    <td align="left" rowspan="1" colspan="1">1.56, 3.12, 6.25, 12.5, 25, 50, 100 μM</td>
    <td rowspan="1" colspan="1">LDH production level</td>
    <td align="left" rowspan="1" colspan="1">Compound 6 (3,5-dicaffeoylquinic acid ethyl ester) exhibited a more potent cytoprotective effect thus selected for further evaluation.</td>
    <td rowspan="6" colspan="1">
     <xref rid="B101" ref-type="bibr">Yu et al. (2016)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Nine caffeoylquinic acid analogs (1–9) isolated from ethanol extract</td>
    <td rowspan="5" colspan="1"> 
     <italic>In vitro</italic> study stimulated by H2O2
    </td>
    <td rowspan="1" colspan="1"> 1 h pre-treatment</td>
    <td rowspan="1" colspan="1">Mitochondrial membrane potential (Δψm)</td>
    <td align="left" rowspan="1" colspan="1">↓ LDH leakage at 6.25, 12.5, 25, 50 and 100 μM compound 6.</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
    <td rowspan="4" colspan="1">Phosphorylation of ERK, JNK, and p38</td>
    <td align="left" rowspan="1" colspan="1">↑↑↑ Δψm in cells cultured with compound 6 (6.25, 12.5, 25.0 μM).</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
    <td rowspan="3" colspan="1">↓ Phosphorylation of JNK and ERK by 12.5 and 25.0 μM compound 6</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (0.3 mM H2O2)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Positive control (Carbonyl cyanide 
     <italic>m</italic>-chlorophenylhydrazone (CCCP) for Δψm)
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">24 Swiss albino mice (6 mice/group)</td>
    <td rowspan="1" colspan="1">250 and 500 mg/kg body weight</td>
    <td rowspan="1" colspan="1">Xylene-induced ear edema test</td>
    <td rowspan="6" colspan="1">250 and 500 mg/kg GN extract ↓ xylene-induced ear edema and carrageenan-induced models of inflammation.</td>
    <td rowspan="6" colspan="1">
     <xref rid="B57" ref-type="bibr">Rahman et al. (2018)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Extract (Ethanol)</td>
    <td rowspan="5" colspan="1"> 
     <italic>In vivo</italic> study using mice model with induced inflammation
    </td>
    <td rowspan="1" colspan="1"> Oral route</td>
    <td rowspan="5" colspan="1">Carrageenan-induced paw edema test</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> 1 h before infection</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (distilled water + 20 μl xylene, saline + injection of 0.1 ml 1% carrageenan)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Positive control (100 mg/kg diclofenac sodium)</td>
   </tr>
   <tr>
    <td rowspan="7" colspan="1">
     <italic>Gynura formosana</italic> Kitam.
    </td>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="1" colspan="1">48 male Sprague-Dawley rats (8 rats/group)</td>
    <td rowspan="1" colspan="1">100 mg/kg, 250 mg/kg, 500 mg/kg body weight</td>
    <td rowspan="1" colspan="1">Cotton pellet granuloma assay</td>
    <td rowspan="1" colspan="1">GF dose-dependently ↓ granuloma formation.</td>
    <td rowspan="7" colspan="1">
     <xref rid="B44" ref-type="bibr">Ma et al. (2017)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="6" colspan="1">Extract (Ethyl acetate)</td>
    <td rowspan="6" colspan="1"> 
     <italic>In vivo</italic> study using cotton pellet-induced granuloma rat model
    </td>
    <td rowspan="1" colspan="1"> Oral route</td>
    <td rowspan="6" colspan="1">LDH, GPT, CRP, TNF-α and IL-1β production level using ELISA</td>
    <td rowspan="2" colspan="1">100, 250, and 500 mg/kg GF ↓ levels of plasma inflammatory biomarkers (LDH, GPT and CRP) activities.</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Once daily for 7 days</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups:</td>
    <td rowspan="4" colspan="1">GF dose-dependently ↓ plasma pro-inflammatory cytokines (TNF-α and IL-1β).</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (0.5% carboxymethylcellulose, 1 ml/kg)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Standard drug (4 mg/kg indomethacin)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>↑ indicates significantly induce (
    <italic>p</italic> &lt; 0.05), ↑↑ indicates significantly induce (
    <italic>p</italic> &lt; 0.01), ↑↑↑ indicates significantly induce (
    <italic>p</italic> &lt; 0.001), ↓ indicates significantly inhibit (
    <italic>p</italic> &lt; 0.05), ↓↓ indicates significantly inhibit (
    <italic>p</italic> &lt; 0.01), and ↓↓↓ indicates significantly inhibit (
    <italic>p</italic> &lt; 0.001).
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
